0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Nuclear Medicine Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-8W14462
Home | Market Reports | Health| Pharmacy
Global Nuclear Medicine Therapy Market Research Report 2023
BUY CHAPTERS

Nuclear Medicine Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8W14462
Report
October 2024
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nuclear Medicine Therapy - Market Size

The global market for Nuclear Medicine Therapy was estimated to be worth US$ 1771 million in 2023 and is forecast to a readjusted size of US$ 4734 million by 2030 with a CAGR of 15.1% during the forecast period 2024-2030

Nuclear Medicine Therapy - Market

Nuclear Medicine Therapy - Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nuclear Medicine Therapy by region & country, by Type, and by Application.
The Nuclear Medicine Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Therapy.
Market Segmentation

Scope of Nuclear Medicine Therapy - Market Report

Report Metric Details
Report Name Nuclear Medicine Therapy - Market
Forecasted market size in 2030 US$ 4734 million
CAGR 15.1%
Forecasted years 2024 - 2030
Segment by Type:
  • Radium-223
  • Lutetium-177
  • Iodine-131
  • Other
Segment by Application
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Nuclear Medicine Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Nuclear Medicine Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Nuclear Medicine Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Nuclear Medicine Therapy - Market size in 2030?

Ans: The Nuclear Medicine Therapy - Market size in 2030 will be US$ 4734 million.

Who are the main players in the Nuclear Medicine Therapy - Market report?

Ans: The main players in the Nuclear Medicine Therapy - Market are Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma

What are the Application segmentation covered in the Nuclear Medicine Therapy - Market report?

Ans: The Applications covered in the Nuclear Medicine Therapy - Market report are Thyroid, Bone Metastasis, Lymphoma, Other

What are the Type segmentation covered in the Nuclear Medicine Therapy - Market report?

Ans: The Types covered in the Nuclear Medicine Therapy - Market report are Radium-223, Lutetium-177, Iodine-131, Other

1 Market Overview
1.1 Nuclear Medicine Therapy Product Introduction
1.2 Global Nuclear Medicine Therapy Market Size Forecast
1.3 Nuclear Medicine Therapy Market Trends & Drivers
1.3.1 Nuclear Medicine Therapy Industry Trends
1.3.2 Nuclear Medicine Therapy Market Drivers & Opportunity
1.3.3 Nuclear Medicine Therapy Market Challenges
1.3.4 Nuclear Medicine Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nuclear Medicine Therapy Players Revenue Ranking (2023)
2.2 Global Nuclear Medicine Therapy Revenue by Company (2019-2024)
2.3 Key Companies Nuclear Medicine Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Nuclear Medicine Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Nuclear Medicine Therapy
2.6 Nuclear Medicine Therapy Market Competitive Analysis
2.6.1 Nuclear Medicine Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Nuclear Medicine Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Radium-223
3.1.2 Lutetium-177
3.1.3 Iodine-131
3.1.4 Other
3.2 Global Nuclear Medicine Therapy Sales Value by Type
3.2.1 Global Nuclear Medicine Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nuclear Medicine Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Nuclear Medicine Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Thyroid
4.1.2 Bone Metastasis
4.1.3 Lymphoma
4.1.4 Other
4.2 Global Nuclear Medicine Therapy Sales Value by Application
4.2.1 Global Nuclear Medicine Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nuclear Medicine Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Nuclear Medicine Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Nuclear Medicine Therapy Sales Value by Region
5.1.1 Global Nuclear Medicine Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nuclear Medicine Therapy Sales Value by Region (2019-2024)
5.1.3 Global Nuclear Medicine Therapy Sales Value by Region (2025-2030)
5.1.4 Global Nuclear Medicine Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Nuclear Medicine Therapy Sales Value, 2019-2030
5.2.2 North America Nuclear Medicine Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Nuclear Medicine Therapy Sales Value, 2019-2030
5.3.2 Europe Nuclear Medicine Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Nuclear Medicine Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Nuclear Medicine Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Nuclear Medicine Therapy Sales Value, 2019-2030
5.5.2 South America Nuclear Medicine Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Nuclear Medicine Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Nuclear Medicine Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nuclear Medicine Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nuclear Medicine Therapy Sales Value
6.3 United States
6.3.1 United States Nuclear Medicine Therapy Sales Value, 2019-2030
6.3.2 United States Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nuclear Medicine Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nuclear Medicine Therapy Sales Value, 2019-2030
6.4.2 Europe Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nuclear Medicine Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nuclear Medicine Therapy Sales Value, 2019-2030
6.5.2 China Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nuclear Medicine Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nuclear Medicine Therapy Sales Value, 2019-2030
6.6.2 Japan Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nuclear Medicine Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nuclear Medicine Therapy Sales Value, 2019-2030
6.7.2 South Korea Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nuclear Medicine Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nuclear Medicine Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nuclear Medicine Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nuclear Medicine Therapy Sales Value, 2019-2030
6.9.2 India Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nuclear Medicine Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bayer
7.1.1 Bayer Profile
7.1.2 Bayer Main Business
7.1.3 Bayer Nuclear Medicine Therapy Products, Services and Solutions
7.1.4 Bayer Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Bayer Recent Developments
7.2 Novartis
7.2.1 Novartis Profile
7.2.2 Novartis Main Business
7.2.3 Novartis Nuclear Medicine Therapy Products, Services and Solutions
7.2.4 Novartis Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Novartis Recent Developments
7.3 China Isotope & Radiation
7.3.1 China Isotope & Radiation Profile
7.3.2 China Isotope & Radiation Main Business
7.3.3 China Isotope & Radiation Nuclear Medicine Therapy Products, Services and Solutions
7.3.4 China Isotope & Radiation Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Dongcheng Recent Developments
7.4 Dongcheng
7.4.1 Dongcheng Profile
7.4.2 Dongcheng Main Business
7.4.3 Dongcheng Nuclear Medicine Therapy Products, Services and Solutions
7.4.4 Dongcheng Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Dongcheng Recent Developments
7.5 Q BioMed
7.5.1 Q BioMed Profile
7.5.2 Q BioMed Main Business
7.5.3 Q BioMed Nuclear Medicine Therapy Products, Services and Solutions
7.5.4 Q BioMed Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 Q BioMed Recent Developments
7.6 Curium Pharmaceuticals
7.6.1 Curium Pharmaceuticals Profile
7.6.2 Curium Pharmaceuticals Main Business
7.6.3 Curium Pharmaceuticals Nuclear Medicine Therapy Products, Services and Solutions
7.6.4 Curium Pharmaceuticals Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 Curium Pharmaceuticals Recent Developments
7.7 Jubilant Radiopharma
7.7.1 Jubilant Radiopharma Profile
7.7.2 Jubilant Radiopharma Main Business
7.7.3 Jubilant Radiopharma Nuclear Medicine Therapy Products, Services and Solutions
7.7.4 Jubilant Radiopharma Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 Jubilant Radiopharma Recent Developments
7.8 Lantheus
7.8.1 Lantheus Profile
7.8.2 Lantheus Main Business
7.8.3 Lantheus Nuclear Medicine Therapy Products, Services and Solutions
7.8.4 Lantheus Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Lantheus Recent Developments
7.9 Aurobindo Pharma
7.9.1 Aurobindo Pharma Profile
7.9.2 Aurobindo Pharma Main Business
7.9.3 Aurobindo Pharma Nuclear Medicine Therapy Products, Services and Solutions
7.9.4 Aurobindo Pharma Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 Aurobindo Pharma Recent Developments
7.10 International Isotopes
7.10.1 International Isotopes Profile
7.10.2 International Isotopes Main Business
7.10.3 International Isotopes Nuclear Medicine Therapy Products, Services and Solutions
7.10.4 International Isotopes Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 International Isotopes Recent Developments
7.11 Mundipharma
7.11.1 Mundipharma Profile
7.11.2 Mundipharma Main Business
7.11.3 Mundipharma Nuclear Medicine Therapy Products, Services and Solutions
7.11.4 Mundipharma Nuclear Medicine Therapy Revenue (US$ Million) & (2019-2024)
7.11.5 Mundipharma Recent Developments
8 Industry Chain Analysis
8.1 Nuclear Medicine Therapy Industrial Chain
8.2 Nuclear Medicine Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nuclear Medicine Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Nuclear Medicine Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Nuclear Medicine Therapy Market Trends
    Table 2. Nuclear Medicine Therapy Market Drivers & Opportunity
    Table 3. Nuclear Medicine Therapy Market Challenges
    Table 4. Nuclear Medicine Therapy Market Restraints
    Table 5. Global Nuclear Medicine Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Nuclear Medicine Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Nuclear Medicine Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Nuclear Medicine Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Nuclear Medicine Therapy
    Table 10. Global Nuclear Medicine Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Nuclear Medicine Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Nuclear Medicine Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Nuclear Medicine Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Nuclear Medicine Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Nuclear Medicine Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Nuclear Medicine Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Nuclear Medicine Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Nuclear Medicine Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Nuclear Medicine Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Nuclear Medicine Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Nuclear Medicine Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Nuclear Medicine Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Nuclear Medicine Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Nuclear Medicine Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Nuclear Medicine Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Nuclear Medicine Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Nuclear Medicine Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Nuclear Medicine Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bayer Basic Information List
    Table 32. Bayer Description and Business Overview
    Table 33. Bayer Nuclear Medicine Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Nuclear Medicine Therapy Business of Bayer (2019-2024)
    Table 35. Bayer Recent Developments
    Table 36. Novartis Basic Information List
    Table 37. Novartis Description and Business Overview
    Table 38. Novartis Nuclear Medicine Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Nuclear Medicine Therapy Business of Novartis (2019-2024)
    Table 40. Novartis Recent Developments
    Table 41. China Isotope & Radiation Basic Information List
    Table 42. China Isotope & Radiation Description and Business Overview
    Table 43. China Isotope & Radiation Nuclear Medicine Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Nuclear Medicine Therapy Business of China Isotope & Radiation (2019-2024)
    Table 45. China Isotope & Radiation Recent Developments
    Table 46. Dongcheng Basic Information List
    Table 47. Dongcheng Description and Business Overview
    Table 48. Dongcheng Nuclear Medicine Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Nuclear Medicine Therapy Business of Dongcheng (2019-2024)
    Table 50. Dongcheng Recent Developments
    Table 51. Q BioMed Basic Information List
    Table 52. Q BioMed Description and Business Overview
    Table 53. Q BioMed Nuclear Medicine Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Nuclear Medicine Therapy Business of Q BioMed (2019-2024)
    Table 55. Q BioMed Recent Developments
    Table 56. Curium Pharmaceuticals Basic Information List
    Table 57. Curium Pharmaceuticals Description and Business Overview
    Table 58. Curium Pharmaceuticals Nuclear Medicine Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Nuclear Medicine Therapy Business of Curium Pharmaceuticals (2019-2024)
    Table 60. Curium Pharmaceuticals Recent Developments
    Table 61. Jubilant Radiopharma Basic Information List
    Table 62. Jubilant Radiopharma Description and Business Overview
    Table 63. Jubilant Radiopharma Nuclear Medicine Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Nuclear Medicine Therapy Business of Jubilant Radiopharma (2019-2024)
    Table 65. Jubilant Radiopharma Recent Developments
    Table 66. Lantheus Basic Information List
    Table 67. Lantheus Description and Business Overview
    Table 68. Lantheus Nuclear Medicine Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Nuclear Medicine Therapy Business of Lantheus (2019-2024)
    Table 70. Lantheus Recent Developments
    Table 71. Aurobindo Pharma Basic Information List
    Table 72. Aurobindo Pharma Description and Business Overview
    Table 73. Aurobindo Pharma Nuclear Medicine Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Nuclear Medicine Therapy Business of Aurobindo Pharma (2019-2024)
    Table 75. Aurobindo Pharma Recent Developments
    Table 76. International Isotopes Basic Information List
    Table 77. International Isotopes Description and Business Overview
    Table 78. International Isotopes Nuclear Medicine Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Nuclear Medicine Therapy Business of International Isotopes (2019-2024)
    Table 80. International Isotopes Recent Developments
    Table 81. Mundipharma Basic Information List
    Table 82. Mundipharma Description and Business Overview
    Table 83. Mundipharma Nuclear Medicine Therapy Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Nuclear Medicine Therapy Business of Mundipharma (2019-2024)
    Table 85. Mundipharma Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Nuclear Medicine Therapy Downstream Customers
    Table 89. Nuclear Medicine Therapy Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Nuclear Medicine Therapy Product Picture
    Figure 2. Global Nuclear Medicine Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Nuclear Medicine Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Nuclear Medicine Therapy Report Years Considered
    Figure 5. Global Nuclear Medicine Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Medicine Therapy Revenue in 2023
    Figure 7. Nuclear Medicine Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Radium-223 Picture
    Figure 9. Lutetium-177 Picture
    Figure 10. Iodine-131 Picture
    Figure 11. Other Picture
    Figure 12. Global Nuclear Medicine Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Nuclear Medicine Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Thyroid
    Figure 15. Product Picture of Bone Metastasis
    Figure 16. Product Picture of Lymphoma
    Figure 17. Product Picture of Other
    Figure 18. Global Nuclear Medicine Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Nuclear Medicine Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Nuclear Medicine Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Nuclear Medicine Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Nuclear Medicine Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Nuclear Medicine Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Nuclear Medicine Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Nuclear Medicine Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Nuclear Medicine Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Nuclear Medicine Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Nuclear Medicine Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Nuclear Medicine Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Nuclear Medicine Therapy Sales Value (%), (2019-2030)
    Figure 31. United States Nuclear Medicine Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Nuclear Medicine Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Nuclear Medicine Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Nuclear Medicine Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Nuclear Medicine Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Nuclear Medicine Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Nuclear Medicine Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Nuclear Medicine Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Nuclear Medicine Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Nuclear Medicine Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Nuclear Medicine Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Nuclear Medicine Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Nuclear Medicine Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Nuclear Medicine Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Nuclear Medicine Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 52. Nuclear Medicine Therapy Industrial Chain
    Figure 53. Nuclear Medicine Therapy Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS